SCHEMBL7221176

SCHEMBL7221176

COc1ccc(C(c2ccc(O)cc2)c2cccc3ccccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.49
NR3C1 P04150 1/20 0.48
PGR P06401 1/20 0.48
NR3C2 P08235 1/20 0.48
AR P10275 1/20 0.48
KMT2A Q03164 4/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 2/20 0.45
NQO1 P15559 1/20 0.44
LTA4H P09960 1/20 0.43
ESR2 Q92731 1/20 0.43
GAA P10253 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GLA P06280 2/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13295547 0.89 NR3C1 (0.58) AHRNR3C1PGRNR3C2AR
SCHEMBL13295548 0.89 NR3C1 (0.50) AHRNR3C1PGRNR3C2AR
SCHEMBL29368878 0.87 ALDH1A1 (0.51) KMT2ANQO1GAAALDH1A1SLC6A4
SCHEMBL333444 0.87 ALDH1A1 (0.51) KMT2ANQO1GAAALDH1A1SLC6A4
SCHEMBL7221231 0.84 AHR (0.49) AHRNR3C1PGRNR3C2AR
SCHEMBL7221229 0.80 KMT2A (0.48) AHRKMT2ARAB9ANPC1GAA
SCHEMBL14564174 0.79 ELANE (0.47) AHRKMT2AGAAALDH1A1KDM4E
SCHEMBL28812693 0.78 HPRT1 (0.47) KMT2ANQO1GAAALDH1A1MEN1
SCHEMBL5024819 0.77 ACP3 (0.56) NR3C1PGRNR3C2ARLTA4H
SCHEMBL4457608 0.77 KMT2A (0.48) AHRNR3C1PGRNR3C2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610705-B1 Treating breast cancer, osteoporosis, hypercholesteremia or endometriosis COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-08-26 US disclosed